Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
Viva Biotech announced a significant financial turnaround for 2024, with revenue reaching RMB1,986.7 million and a net profit of RMB222.0 million, marking a recovery from the previous year's losses.
The International Institute for Brain Enhancement has partnered with NeuralCure AI to revolutionize PTSD treatment for veterans using advanced AI and neuroscience technologies.
Corundum Systems Biology is supporting Pheno.AI's Human Phenotype Project as it expands into Japan, aiming to enhance AI-driven health research.
Yoda Therapeutics has dosed the first patient in its Phase 2 trial of YA-101 for Multiple System Atrophy, a rare neurodegenerative disorder.
Fangzhou Inc. has announced a strategic collaboration with Tencent Health and Tencent Cloud to enhance AI-driven healthcare solutions by integrating the DeepSeek AI model.
Healthcare.com has introduced Autopilot, an AI-powered platform designed to enhance health insurance distribution by matching consumers with distributors using proprietary data.
VisiQuate has acquired Rotera to strengthen its AI-driven revenue cycle management capabilities, enhancing automation in healthcare.
Health In Tech has announced a collaboration with DialCare to integrate virtual primary care and behavioral health services into its health plan offerings, enhancing access to affordable healthcare.
NodeAI, a startup from Hamilton, Ontario, has won the Falcons' Fortunes 2025 competition for its AI-driven lung cancer diagnostics technology.
Prendio-BioProcure has launched new AI-driven capabilities to streamline procurement processes for biotech companies, enhancing efficiency and cost savings.
Arlo has announced $4 million in seed funding to enhance its AI-driven health insurance solutions for small businesses, with support from Upfront Ventures, 8VC, and General Catalyst.
XRP Healthcare has announced plans to go public by Q3 2025, accelerating its AI and M&A strategies, according to a press release.
Navina has raised $55 million in a Series C funding round led by Goldman Sachs Alternatives, aiming to expand its AI-powered clinical intelligence platform.
AIRA Matrix and Gestalt Diagnostics have partnered to integrate AI-driven quality control into pathology workflows, enhancing diagnostic precision and efficiency.
Avatar Medical has received FDA 510(k) clearance for its brAIn SPS, a shoulder positioning system developed with FX Shoulder Solutions, enhancing preoperative planning with AI-driven imaging.
PhaseV will showcase its new AI/ML-powered clinical trial design and analysis capabilities at the CMO Summit 360° in Boston, enhancing trial success prediction and planning.
Gestalt Diagnostics has announced a global reseller partnership with DLS Pathology Services to expand its digital pathology solutions in Australia and beyond.
Noul Co., Ltd. presented its AI-powered cervical cancer screening technology at NVIDIA GTC 2025, highlighting its miLab™ CER platform.
Brainomix has completed an $18 million Series C funding round to advance its AI imaging technology for stroke and lung fibrosis, with plans to expand in the US.
Pearl and Medit have announced a partnership to integrate AI-powered diagnostic solutions into the Medit Link platform, enhancing dental diagnostics and patient communication.
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
